Corcept Therapeutics | CORT - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Acadia Pharmaceuticals USD 171.09M 1.9M 2026-03
Alaunos Therapeutics USD 2.38M 172K 2026-03
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Ardelyx USD 246.97M 2.62M 2026-03
Aurora Cannabis CAD 58.95M 2.24M 2026-03
BioMarin Pharmaceutical USD 193.54M 267K 2026-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Canopy Growth CAD 422.07M 53.78M 2026-03
Corcept Therapeutics USD 107.33M 1.36M 2026-03
Eli Lilly USD 943.5M 3.33M 2026-03
J&J USD 2.41B 1.64M 2026-06
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Lexicon Pharmaceuticals USD 363.47M 67K 2025-12
Merck USD 2.47B 4.93M 2026-03
Nektar Therapeutics USD 29.47M 9.09M 2026-03
Novartis USD 1.9B 7.38M 2026-06
Novartis USD 1.91B 60K 2026-03
Omeros USD 611K 17K 2023-12
Pacira USD 39.82M 512K 2026-06
Pfizer USD 5.7B 0 2026-06
Supernus Pharmaceuticals USD 58.16M 124K 2026-06
TG Therapeutics USD 153.08M 2.23M 2026-06